Our last differential comparison was based on the CHD1L protein levels analysis in normal and tumor tissues and again the trend of elevated CHD1L expression in tumor tissues was observed in LUAD, LIHC, glioblastoma multiforme, colon, and breast cancers where IHC staining, that was high for CHD1L in analyzed tumor tissues, confirmed our findings. Here, CHD1L is linked to breast carcinoma.